In addition, univariate (Fig. 1h) and multivariate (Fig. 1i) regression analyses of cohort 2 demonstrated that NR4A1 expression was an independent prognostic indicator of BC overall survival, with significant hazard ratios for predicting clinical outcomes. Here, NR4A1 is linked to breast cancer.